Lys Therapeutics raises over $27m to advance new treatments for Parkinson’s and stroke (opens in new tab)

Lys Therapeutics, based in Lyon and Caen, France, has raised more than €25 million since its 2021 founding. The financing package includes a grant of more than $5 million from The Michael J. Fox Foundation for Parkinson’s Research, with additional support from Bpifrance, France 2030 and private investors. The proceeds are intended to support completion […] The post appeared first on <a href="